These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36060608)

  • 21. An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa.
    Bertrand JT; Bidashimwa D; Makani PB; Hernandez JH; Akilimali P; Binanga A
    Contraception; 2018 Nov; 98(5):411-417. PubMed ID: 30120925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study.
    Burke HM; Packer C; Zingani A; Moses P; Bernholc A; Ruderman LW; Martinez A; Chen M
    PLoS One; 2022; 17(10):e0275986. PubMed ID: 36256638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injection.
    Cover J; Namagembe A; Tumusiime J; Lim J; Drake JK; Mbonye AK
    Contraception; 2017 Mar; 95(3):306-311. PubMed ID: 27789309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of Contraceptive Self-Injection with DMPA-SC Among Adolescents in Gulu District, Uganda.
    Cover J; Lim J; Namagembe A; Tumusiime J; Drake JK; Cox CM
    Int Perspect Sex Reprod Health; 2017 Dec; 43(4):153-162. PubMed ID: 29771679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects.
    Liu J; Shen J; Diamond-Smith N
    Contraception; 2018 Nov; 98(5):430-437. PubMed ID: 29733817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable contraception: emerging evidence on subcutaneous self-administration.
    Lerma K; Goldthwaite LM
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):464-470. PubMed ID: 31567445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
    Beasley A; White KO; Cremers S; Westhoff C
    Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Marchi NM; Nakagava HM; de Melo ML; Cristofoletti Mde L; Pellini E; Scozzafave RH; Petta C
    Contraception; 1997 Nov; 56(5):301-4. PubMed ID: 9437558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
    Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
    Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-administration of injectable contraception: a systematic review and meta-analysis.
    Kennedy CE; Yeh PT; Gaffield ML; Brady M; Narasimhan M
    BMJ Glob Health; 2019; 4(2):e001350. PubMed ID: 31179026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal.
    Mvundura M; Di Giorgio L; Morozoff C; Cover J; Ndour M; Drake JK
    Contracept X; 2019; 1():100012. PubMed ID: 32494776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Getting closer to people: family planning provision by drug shops in Uganda.
    Akol A; Chin-Quee D; Wamala-Mucheri P; Namwebya JH; Mercer SJ; Stanback J
    Glob Health Sci Pract; 2014 Nov; 2(4):472-81. PubMed ID: 25611480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda.
    Odwe G; Gray K; Kyarimpa A; Obare F; Nagendi G
    Glob Health Sci Pract; 2018 Dec; 6(4):711-722. PubMed ID: 30429201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi.
    Ali G; Porter Erlank C; Birhanu F; Stanley M; Chirwa J; Kachale F; Gunda A
    Front Glob Womens Health; 2023; 4():1059408. PubMed ID: 37034400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction strategies raise key questions.
    Finger WR; Keller S
    Netw Res Triangle Park N C; 1995 Sep; 16(1):4-8. PubMed ID: 12290471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.
    Stout A; Wood S; Barigye G; Kaboré A; Siddo D; Ndione I
    Glob Health Sci Pract; 2018 Mar; 6(1):55-72. PubMed ID: 29602866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
    Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK
    Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.